BHST: BioHarvest Kompaniya qiymatining sof foydaga nisbati

BioHarvest Sciences, Inc. (BHST) korporativ emblemasi va logotipi

BioHarvest Sciences (BHST) pestitsidlardan foydalanmasdan, sof o'simlik komponentlarini sanoat miqyosida ishlab chiqarish uchun innovatsion Bio-Plant CELL usulini joriy qilmoqda. Kompaniya asosiy patentlarning maxfiyligini ichkarida saqlagan holda, logistika va qadoqlash ishlarini pudratchilarga topshiradi. -3.30 metrikasi aks etgan ushbu savdo grafigi, nutraceutical sektoriga xomashyo yetkazib berish uchun o'zining CELLICITATION tizimini kengaytirayotgan va farmatsevtika bozoridagi ta'sirini oshirayotgan biznes tahlilini to'ldiradi.

BHST BioHarvest Sciences Inc: Narx-foyda koeffitsiyenti 13.11.2024 - 13.11.2026 oraligʻida

BioHarvest (BHST) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:bioharvest.com - BHST
BioHarvest Sciences Inc. yetakchi tovari

BioHarvest Sciences (BHST) o'zining noyob hujayrasiz o'simliklar o'sish texnologiyasi tufayli mustahkam pozitsiyani saqlab qolmoqda. P/E baholash tahlili biznesning joriy bozor qiymatini uning haqiqiy sof foydasi bilan solishtirish imkonini beradi. Ushbu koeffitsient bir dollar foydaning tannarxini o'lchaydi, bunda ko'rsatkich valyuta buzilishlari va bozordagi bir martalik keskin ko'tarilishlardan tozalanadi. Investorlar shuni yodda tutishlari kerakki, ekologik mahsulotlarga yuqori sodiqlikka qaramay, pasaygan koeffitsient daromadlarning kamayishidan dalolat berishi mumkin.

Muhim raqobatchilar

P/E multiplikatori haleon.com|Narx-foyda koeffitsiyenti KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Jyong Biotech Corp MENS|Ligand Corp (LGND) - Kapitalizatsiyaning foydaga nisbati|AMRX: Narx-foyda koeffitsiyenti|perrigo.com - Bozor narxining sof foydaga nisbati|ALVO: P/E multiplikatori|Liquidia Corp - Kompaniya qiymatining sof foydaga nisbati|GLPG (Galapagos Genomics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati ANI Pharmaceuticals Corp ANIP|Narxning foydaga nisbati MannKind Corporation (MNKD)|AMPH (amphastar.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori PCRX (Pacira BioSciences, Inc.)|ARS Pharmaceuticals Inc - Narxning foydaga nisbati|Theravance - P/E multiplikatori|Biznesning o‘zini qoplash muddati Aquestive Corp AQST|scpharmaceuticals.com (SCPH) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Tectonic Therapeutic (TECX)|TNXP (Tonix Pharmaceuticals Holding Corp.) - P/E multiplikatori|SXTC: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EPRX|P/E multiplikatori Invizyne (EXOZ)|Narxning foydaga nisbati Oramed Pharmaceuticals Inc. ORMP|Kompaniya qiymatining sof foydaga nisbati ENTX|HYFT: Narx-foyda koeffitsiyenti|ABVC: Narxning foydaga nisbati|CPIX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Quantum BioPharma Corp (QNTM)|Narxning foydaga nisbati FibroGen, Inc.|telomirpharma.com (TELO) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti RANI (Rani Therapeutics)|Bozor narxining sof foydaga nisbati SNYR|Rallybio - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati LEXX|PULM - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Pheton Holdings Ltd PTHL|APM: P/E multiplikatori|Narx-foyda koeffitsiyenti Lyra Therapeutics Inc.|IBO (Impact BioMedical) - P/E multiplikatori|TNF Pharma (TNFA) - Biznesning o‘zini qoplash muddati|P/E multiplikatori YCBD|PRFX - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Altamira Therapeutics Ltd. CYTO|LIPO: Narx-foyda multiplikatori|Optinose - P/E multiplikatori|Pieris Pharma (PIRS) - Narx-foyda koeffitsiyenti|PROC: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati petrospharma.com (PTPI)|Narxning foydaga nisbati Qilian International Holding|Acelyrin Inc. (SLRN) - Biznesning o‘zini qoplash muddati|P/E multiplikatori TFFP